Buy ORENCIA 125 mg/mL abatacept

ORENCIA 125 mg/mL is a subcutaneous injection solution containing abatacept. This medication is commonly used to manage symptoms of autoimmune conditions. Learn more about its uses and effects.

Strength

125 mg/mL

Pack Size

1 SYRINGE, GLASS in 1 CARTON (0003-2188-21) / 1 mL in 1 SYRINGE, GLASS

Manufacturer / TM Owner

E.R. Squibb & Sons, L.L.C.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Uses / Indications

ORENCIA 125 mg/mL is primarily used for the treatment of autoimmune conditions. It works by modulating the immune system to reduce inflammation and alleviate symptoms. People often wonder, 'What is ORENCIA used for?' It is commonly prescribed for conditions like rheumatoid arthritis and other inflammatory disorders.

Side Effects

Common effects of ORENCIA 125 mg/mL may include redness or swelling at the injection site. Some individuals might experience mild to moderate discomfort. It's important to monitor for any unusual reactions and consult a healthcare provider if concerns arise.

Precautions & Warnings

ORENCIA 125 mg/mL should be handled with care. Store it at the recommended temperature and keep it out of reach of children. Always follow the instructions provided by your healthcare provider for safe administration. Do not use if the solution appears discolored or contains particles.

Avoid Interactions

ORENCIA 125 mg/mL may interact with other medications, including those that affect the immune system. It's important to inform your healthcare provider about all medications you are taking. Avoid alcohol while using this medication, as it may increase the risk of side effects.

References

Frequently Asked Questions

ORENCIA 125 mg/mL is used to manage symptoms of autoimmune conditions, such as rheumatoid arthritis.

ORENCIA 125 mg/mL is administered subcutaneously. Follow the instructions provided by your healthcare provider for proper administration.

Common side effects may include redness or swelling at the injection site, and mild to moderate discomfort.

ORENCIA 125 mg/mL may interact with other medications. Consult your healthcare provider before combining it with other treatments.

ORENCIA 125 mg/mL should be stored at the recommended temperature and kept out of reach of children.

Published by GNH India Pharmaceuticals Limited

Last updated: 18 May 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.